Published in J Hepatol on May 01, 2004
Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis (2005) 2.55
Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet Res (2010) 2.26
Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis (2006) 1.84
Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J Clin Microbiol (2004) 1.42
Hepatitis E outbreak on cruise ship. Emerg Infect Dis (2009) 1.37
Hepatitis E virus: foodborne, waterborne and zoonotic transmission. Int J Environ Res Public Health (2013) 1.23
Hepatitis E virus in pork liver sausage, France. Emerg Infect Dis (2013) 1.15
Inactivation of infectious hepatitis E virus present in commercial pig livers sold in local grocery stores in the United States. Int J Food Microbiol (2007) 1.11
Transmission dynamics of hepatitis E among swine: potential impact upon human infection. BMC Vet Res (2007) 1.09
Transmission of hepatitis E virus from rabbits to cynomolgus macaques. Emerg Infect Dis (2013) 0.99
Possible zoonotic transmission of hepatitis E from pet pig to its owner. Emerg Infect Dis (2007) 0.97
High hepatitis E virus seroprevalence in forestry workers and in wild boars in France. J Clin Microbiol (2012) 0.95
Using improved technology for filter paper-based blood collection to survey wild Sika deer for antibodies to hepatitis E virus. J Virol Methods (2007) 0.92
Clinical characteristics and risk factors of sporadic Hepatitis E in central China. Virol J (2011) 0.89
Hepatitis E: a complex and global disease. Emerg Health Threats J (2008) 0.89
Thermal stability of hepatitis E virus assessed by a molecular biological approach. Virol J (2011) 0.89
Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon (2012) 0.85
Genotype-4 hepatitis E in a human after ingesting roe deer meat in South Korea. Clin Mol Hepatol (2013) 0.83
The prevalence of hepatitis E virus infections among swine, swine farmers and the general population in Guangdong Province, China. PLoS One (2014) 0.79
Zoonotic Hepatitis E Virus: Classification, Animal Reservoirs and Transmission Routes. Viruses (2016) 0.75
Markers for Ongoing or Previous Hepatitis E Virus Infection Are as Common in Wild Ungulates as in Humans in Sweden. Viruses (2016) 0.75
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology (2004) 2.16
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology (2007) 2.08
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. J Gastroenterol (2005) 2.07
Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res (2005) 1.80
NUCLEOPORIN85 is required for calcium spiking, fungal and bacterial symbioses, and seed production in Lotus japonicus. Plant Cell (2007) 1.71
Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol (2004) 1.52
Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol (2002) 1.50
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology (2006) 1.43
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int (2006) 1.40
Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet (2011) 1.31
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B. J Clin Microbiol (2011) 1.25
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat (2014) 1.23
Genetics of symbiosis in Lotus japonicus: recombinant inbred lines, comparative genetic maps, and map position of 35 symbiotic loci. Mol Plant Microbe Interact (2006) 1.21
Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies. J Gastroenterol (2014) 1.19
Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol (2003) 1.14
Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2. J Clin Microbiol (2007) 1.14
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol (2010) 1.13
Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int (2006) 1.12
ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C. Hepatol Res (2010) 1.09
Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases. Hepatology (2005) 1.08
Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2004) 1.08
Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology (2006) 1.07
Positive and negative regulation of cortical cell division during root nodule development in Lotus japonicus is accompanied by auxin response. Development (2012) 1.07
CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun (2008) 1.04
Familial Mediterranean fever in Japan. Medicine (Baltimore) (2012) 1.04
Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol (2006) 1.04
Toll-like receptor expression in lupus peripheral blood mononuclear cells. J Rheumatol (2007) 1.04
T cell immunity in autoimmune hepatitis. Autoimmun Rev (2005) 1.03
The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer (2003) 1.03
Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology (2008) 1.03
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol (2005) 1.03
Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease. Transl Res (2008) 1.02
Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J Gastroenterol (2004) 1.02
Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int (2007) 1.02
Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology (2003) 1.02
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology (2014) 1.01
Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett (2008) 1.01
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology (2003) 1.00
Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest (2005) 1.00
QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals. J Pharmacol Sci (2005) 1.00
Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol (2003) 1.00
Host plant genome overcomes the lack of a bacterial gene for symbiotic nitrogen fixation. Nature (2009) 1.00
Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study. Hepatol Res (2014) 1.00
Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology (2008) 1.00
T cell immunity and graft-versus-host disease (GVHD). Autoimmun Rev (2005) 0.99
Factors contributing to ribavirin-induced anemia. J Gastroenterol Hepatol (2004) 0.99
Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study). Liver Int (2011) 0.97
Liver cell adenoma with malignant transformation: a case report. World J Gastroenterol (2003) 0.97
The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett (2004) 0.96
Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun (2005) 0.96
Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer (2002) 0.95
Expression of beta-catenin in hepatocellular carcinoma. World J Gastroenterol (2005) 0.94
Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res (2011) 0.94
Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol (2004) 0.94
Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology (2003) 0.92
Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations. Clin Immunol (2002) 0.92
Identification of symbiotically defective mutants of Lotus japonicus affected in infection thread growth. Mol Plant Microbe Interact (2006) 0.91
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study. Hepatol Res (2008) 0.91
[Case of domestically infected hepatitis E with marked thrombocytopenia]. Nihon Shokakibyo Gakkai Zasshi (2008) 0.91
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice. Neuropharmacology (2012) 0.91
Endoscopic identification of Peyer's patches of the terminal ileum in a patient with Crohn's disease. World J Gastroenterol (2004) 0.90
Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells. Life Sci (2005) 0.89